ClinicalTrials.Veeva

Menu

Wormwood in Chronic Progressive Disorders With Reduced Appetite

U

University Hospital Freiburg

Status

Unknown

Conditions

Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01126931
Appetite and Weight Loss

Details and patient eligibility

About

Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer.

Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite

Full description

Supplementation with wormwood in chronic disorders associated with reduced appetite.

Examples:

  1. Cancer
  2. Autoimmune diseases such as Crohns disease and IgA Nephropathy
  3. Old age
  4. Chronic stress and depression

Enrollment

300 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Appetite and weight loss
  • Chronic progressive disease

Exclusion criteria

  • Life expectancy less than 3 months

Trial contacts and locations

1

Loading...

Central trial contact

Simone S Krebs, MD, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems